• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Rosie Riley, USA

    Rosie Riley, USA

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • John Dinon, Australia

    John Dinon, Australia

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Daniel Hare, USA

    Daniel Hare, USA

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Paul Launer, USA

    Paul Launer, USA

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Glen Elison, USA

    Glen Elison, USA

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • John Russo, USA

    John Russo, USA
    final3878

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login